Blurbs

Morgan Stanley Maintains a Buy Rating on Agiliti (AGTI)

Morgan Stanley analyst Drew Ranieri maintained a Buy rating on Agiliti (AGTIResearch Report) today and set a price target of $25.00. The company’s shares closed last Friday at $20.24.

According to TipRanks.com, Ranieri is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -9.7% and a 35.4% success rate. Ranieri covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Baxter International, and Intuitive Surgical.

Agiliti has an analyst consensus of Strong Buy, with a price target consensus of $25.67.

See Insiders’ Hot Stocks on TipRanks >>

Based on Agiliti’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $294 million and net profit of $19.89 million. In comparison, last year the company earned revenue of $235 million and had a net profit of $9.55 million.

Based on the recent corporate insider activity of 77 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AGTI in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Agiliti, Inc. provides end-to-end healthcare technology management and service solutions to the United States healthcare industry. It also offers customers with access to quality healthcare technology and implement comprehensive medical equipment management and service solutions to reduce capital and operating expenses, increase medical equipment and staff productivity and support improved patient safety and outcomes. The company was founded in 1939 and is headquartered in Minneapolis, MN.

Read More on AGTI:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos